Can colorectal cancer mass-screening organization be evidence-based? Lessons from failures: The experimental and pilot phases of the Lazio program

BMC Public Health

Volumn 8, Issue , 2008, Pages

  Federici, Antonio ^a,b   Barca, Alessandra ^a   Baiocchi, Diego ^a   Quadrino, Francesco ^a   Valle, Sabrina ^a   Borgia, Piero ^a   Guasticchi, Gabriella ^a   Giorgi Rossi, Paolo ^a   Anti, M ^c   Casale, V ^c   Di Cicco, M ^c   Stigliano, V ^c   Tammaro, L ^c   Chiriatti, A ^c   Barberani, F ^c   Di Giulio, E ^c   Gabbrielli, A ^c   Stroppa, I ^c   Morini, ^c   Scozzarro, A ^c   Pietropaolo, V ^c   Grassi, A ^c   Bazuro, G ^c   Del Manso, F ^c   Mancini, U ^c   Crespi, M ^c   Amodeo, P ^c   Assorgi, G ^c   Bagarani, M ^c   Schiffino, L ^c   Fracasso, P ^c   Mangia, M L ^c   Ferrara, M ^c   Pippa, G ^c   Vella, A ^c   Vernia, P ^c   Costamagna, G ^c   Petruzzielllo, L ^c   Delle Fave, G ^c   Pallone, F ^c   Capurso, L ^c   more..

^a Agency for Public Health   (Italy)

^b MINISTRY OF HEALTH   (Italy)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; ENDOSCOPY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; AGED; CLINICAL PRACTICE; COLORECTAL TUMOR; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; GASTROINTESTINAL ENDOSCOPY; HEALTH CARE PLANNING; INFORMATION SYSTEM; ITALY; MASS SCREENING; MIDDLE AGED; NONBIOLOGICAL MODEL; OCCULT BLOOD; ORGANIZATION AND MANAGEMENT; PILOT STUDY; PRACTICE GUIDELINE; STANDARD;

AGED; COLORECTAL NEOPLASMS; ENDOSCOPY, GASTROINTESTINAL; EVIDENCE-BASED MEDICINE; FEASIBILITY STUDIES; HUMANS; INFORMATION SYSTEMS; ITALY; MASS SCREENING; MIDDLE AGED; MODELS, ORGANIZATIONAL; OCCULT BLOOD; PHYSICIAN'S PRACTICE PATTERNS; PILOT PROJECTS; PRACTICE GUIDELINES AS TOPIC; REGIONAL MEDICAL PROGRAMS;

EID: 53249113440     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-8-318     Document Type: Article

References (36)

1. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. S Winawer R Fletcher D Rex J Bond R Burt J Ferrucci T Ganiats T Levin S Woolf D Johnson L Kirk S Litin C Simmang Gastrointestinal Consortium Panel, Gastroenterology 2003 124 544 60 10.1053/gast.2003.50044 12557158
2. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. BP Towler L Irwig P Glasziou D Weller J Kewenter, Cochrane Database Syst Rev 2000 2 CD001216 10796760
3. European Code Against Cancer and scientific justification: third version. P Boyle P Autier H Bartelink J Baselga P Boffetta J Burn, Ann Oncol 2003 14 973 1005 10.1093/annonc/mdg305 12853336
4. Screening for colorectal cancer: recommendation and rationale. U.S. Preventive Services Task Force, Ann Intern Med 2002 137 129 31 12118971
5. Disseminating effective cancer screening interventions. RE Glasgow AC Marcus SS Bull KM Wilson, Cancer 2004 101 5 Suppl 1239 50 10.1002/cncr.20509 15316911
6. European Commission European guidelines for quality management in mammography screening. Office for Official Publications of the European Communities Luxembourg 3 2001
7. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. EG Stone SC Morton ME Hulscher MA Maglione EA Roth JM Grimshaw BS Mittman LV Rubenstein LZ Rubenstein PG Shekelle, Ann Intern Med 2002 136 641 51 11992299
8. The determinants of screening uptake and interventions for increasing uptake: a systematic review. R Jepson A Clegg C Forbes R Lewis A Sowden J Kleijnen, Health Technol Assess 2000 4 14 i vii 1-133 10984843
9. Participation in colorectal cancer screening: a review. SW Vernon, J Natl Cancer Inst 1997 89 1406 22 10.1093/jnci/89.19.1406 9326910
10. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. GP Young DJ St John SJ Winawer P Rozen WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy), Am J Gastroenterol 2002 97 2499 507 12385430
11. Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer. G Castiglione M Zappa G Grazzini A Mazzotta M Biagini P Salvadori S Ciatto, Br J Cancer 1996 74 141 4 8679448
12. Factors associated with participation in screening for colorectal cancer with faecal occult blood testing. E Lindholm B Berglund E Haglind J Kewenter, Scand J Gastroenterol 1995 30 171 6 10.3109/00365529509093257 7732341
13. Adherence with colorectal cancer screening guidelines: a review. S Subramanian M Klosterman MM Amonkar TL Hunt, Prev Med 2004 38 536 50 10.1016/j.ypmed.2003.12.011 15066356
14. Colorectal cancer screening awareness in European Primary Care. D Mauri G Pentheroudakis A Milousis A Xilomenos E Panagoulopoulou M Bristianou G Zacharias D Christidis EA Mustou A Gkinosati N Pavlidis, Cancer Detect Prev 2006 30 75 82 10.1016/j.cdp.2005.08.005 16458453
15. A comparison of methods for increasing compliance within a general practitioner based screening project for colorectal cancer and the effect on practitioner workload. G Pye M Christie JO Chamberlain SM Moss JD Hardcastle, J Epidemiol Community Health 1988 42 66 71 3418289
16. Ontario Expert Panel on Colorectal cancer screening, Toronto: Cancer Care 1997
17. Trying to improve the compliance to colorectal cancer screening: a complex study design for a complex planning question. P Giorgi Rossi A Federici F Bartolozzi S Farchi P Borgia G Guasticchi, Cont Clin Trial 2005 26 323 330 10.1016/j.cct.2005.01.005
18. Survey on colorectal cancer screening knowledge, attitudes, and practices of general practice physicians in Lazio, Italy. A Federici P Giorgi Rossi F Bartolozzi S Farchi P Borgia G Guasticchi, Prev Med 2005 41 30 5 10.1016/j.ypmed.2004.11.010 15916990
19. Colorectal cancer screening: recommendations and guideline adherence by physicians from digestive endoscopy centers in the Lazio region - Italy. A Federici S Valle P Giorgi Rossi A Grassi P Borgia G Guasticchi, Prev Med 2006 43 183 186 10.1016/j.ypmed.2006.05.002 16777203
20. The role of GPs in increasing compliance to colorectal cancer screening: a randomised controlled trial. A Federici P Giorgi Rossi F Bartolozzi S Farchi P Borgia G Guasticchi, Cancer Causes Control 2006 17 45 52 10.1007/s10552-005- 0380-9 16411052
21. The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programs: a cluster randomised controlled trial. A Federici P Giorgi Rossi P Borgia F Bartolozzi S Farchi G Guasticchi, J Med Screen 2005 12 83 88 10.1258/0969141053908357 15949119
22. Understanding non-compliance to colorectal cancer screening: a case control study, nested in a randomised trial. P Giorgi Rossi A Federici F Bartolozzi S Farchi P Borgia G Guasticchi, BMC Public Health 5 139 2005 Dec 22 16372903 10.1186/1471-2458-5-139
23. National health Service Clinical governance, Quality in the new NHS Department of Health 1999 http://www.doh.gov.uk
24. Using health care Failure Mode and Effect Analysis: the VA National Center for Patient Safety's prospective risk analysis system. J DeRosier E Stalhandske JP Bagian T Nudell, Jt Comm J Qual Improv 2002 28 248 67 12053459
25. Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy. A Federici C Marinacci M Mangia P Borgia P Giorgi Rossi G Guasticchi, Cancer Detect Prev 2006 30 347 53 10.1016/j.cdp.2006.03.009 16965874
26. [Preliminary results of a mass screening program for colorectal cancer]. L Bedenne G Durand J Faivre C Milan MC Boutron P Arveux P Colombier C Klepping, Gastroenterol Clin Biol 1990 14 140 5 2328881
27. Colorectal cancer management - the role of the GP. H Hanks C Veitch M Harris, Aust Fam Physician 2008 37 259 61 18398525
28. Colorectal cancer screening by fecal occult blood testing: results of a population-based experience. G Grazzini G Castiglione A Isu P Mantellini T Ribeca C Sani P Turco M Zappa, Tumori 2000 86 384 8 11130566
29. Screening for colorectal cancer by once only sigmoidoscopy: a feasibility study in Turin, Italy. C Senore N Segnan FP Rossini R Ferraris M Cavallero F Coppola M Pennazio WS Atkin, J Med Screen 1996 3 72 8 8849763
30. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. SR Cole GP Young D Byrne JR Guy J Morcom, J Med Screen 2002 9 147 52 10.1136/jms.9.4.147 12518003
31. Screening for colorectal cancer in Italy: 2005 survey. M Zorzi A Barca F Falcini G Grazzini R Pizzuti A Ravaioli P Sassoli de Bianchi C Senore A Sigillito M Vettorazzi C Visioli, Epidemiol Prev 2007 31 2-3 Suppl 49 60 17824362
32. Institute of Medicine, Leadership By Example: Coordinating Government Roles in Improving Health Care Policy Washington, DC: National Academy Press 2002
33. Care for chronic diseases. EH Wagner, BMJ 2002 325 913 12399321 10.1136/bmj.325.7370.913
34. Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports. SR Weingarten JM Henning E Badamgarav K Knight V Hasselblad A Gano Jr JJ Ofman, BMJ 2002 325 925 12399340 10.1136/bmj.325.7370.925
35. Weingarten Does disease management improve clinical and economic outcomes in patients with chronic diseases? A systematic review. JJ Ofman E Badamgarav JM Henning K Knight AD Gano Jr RK Levan S Gur-Arie MS Richards V Hasselblad, Am J Med 2004 117 182 92 10.1016/j.amjmed.2004.03.018 15300966
36. Integrated care programmes for chronically ill patients: a review of systematic reviews. Int J Qual Health Care. M Ouwens H Wollersheim R Hermens M Hulscher R Grol, 2005 17 141 6 15665066